Garcinol downregulates Notch1 signaling via modulating miR‐200c and suppresses oncogenic properties of PANC‐1 cancer stem‐like cells
- 24 September 2015
- journal article
- research article
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 64 (2) , 165-173
Abstract
Pancreatic cancer represents one of the most aggressive types of malignancy due to its high resistance toward most clinically available treatments. The presence of pancreatic cancer stem‐like cells (CSCs) has been attributed to the intrinsically high resistance and highly metastatic potential of this disease. Here, we identified and isolated pancreatic CSCs using the side population (SP) method from human pancreatic cancer cell line, PANC‐1. We then compared the SP and non‐SP PANC‐1 cells genetically. PANC‐1 SP cells exhibited CSC properties including enhanced self‐renewal ability, increased metastatic potential, and resistance toward gemcitabine treatment. These cancer stem‐like phenotypes were supported by their enhanced expression of ABCG2, Oct4, and CD44. A traditional plant‐derived antioxidant, garcinol, has been implicated for its anticancer properties. Here, we found that garcinol treatment to PANC‐1 SP cells significantly suppressed the stem‐like properties of PANC‐1 SP cells and metastatic potential by downregulating the expression of Mcl‐1, EZH2, ABCG2, Gli‐1, and Notch1. More importantly, garcinol treatment led to the upregulation of several tumor suppressor microRNAs, and miR‐200c increased by garcinol treatment was found to target and downregulate Notch1. Thus, PANC‐1 SP cells may serve as a model for studying drug‐resistant pancreatic CSCs, and garcinol has the potential as an antagonist against pancreatic CSCs.Keywords
Funding Information
- Chi-Cheng Huang and Alexander T. H. Wu by the Cathay General Hospital-Taipei Medical University joint research fund (101CGH-TMU-06)
This publication has 37 references indexed in Scilit:
- Pancreatic cancer stem cells: New insight into a stubborn diseaseCancer Letters, 2015
- Regulation of cancer metastasis by microRNAsJournal of Biomedical Science, 2015
- Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancerExpert Opinion on Therapeutic Targets, 2015
- Role of microRNAs in maintaining cancer stem cellsAdvanced Drug Delivery Reviews, 2015
- Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeuticsWorld Journal of Gastroenterology, 2014
- Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced Hamster Cheek Pouch Carcinogenesis by a 5-Lipoxygenase Inhibitor, GarcinolNutrition and Cancer, 2012
- Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogsJournal of Hematology & Oncology, 2009
- A Side Order of Stem Cells: The SP PhenotypeStem Cells, 2006
- Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivativesCarcinogenesis, 2005
- An Antibacterial Biphenyl Derivative from Garcinia bancana MIQ.Chemical and Pharmaceutical Bulletin, 2005